Discover real-time Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions.

Aug 15, 2024 · Get real-time updates on Vertex Pharmaceuticals Incorporated Common Stock (VRTX) stock quotes, trades, and more. Make informed investments with Nasdaq.

Get the latest updates on Vertex Pharmaceuticals Incorporated Common Stock (VRTX) pre market trades, share volumes, and more. Make informed investments with Nasdaq.

Jan 6, 2025 · Find the latest Vertex Pharmaceuticals Incorporated Common Stock (VRTX) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq.com.

Find annual and quearterly earnings data for Vertex Pharmaceuticals Incorporated Common Stock (VRTX) including earnings per share, earnings forecasts at Nasdaq.com.

5 days ago · Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication.

Aug 18, 2024 · Find the latest Revenue Earnings Per Share data for Vertex Pharmaceuticals Incorporated Common Stock (VRTX) at Nasdaq.com.

Dec 18, 2024 · Currently trading with a volume of 891,270, the VRTX's price is down by -3.75%, now at $451.64. RSI readings suggest the stock is currently is currently neutral between overbought and oversold.

Jan 22, 2025 · VERTEX PHARMACEUTICALS INC (VRTX) is a large-cap value stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the ...

Oct 1, 2024 · 15 analysts have expressed a variety of opinions on Vertex Pharmaceuticals (NASDAQ: VRTX) over the past quarter, offering a diverse set of opinions from bullish to bearish.